Anthony G. Wilson
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications
Tissue Damage in Rheumatoid Arthritis Is Genetically Linked to Low Peptidylglycine Alpha-Amidating Monooxygenase Activity in Synovial Fibroblasts.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 01, 2025
Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritis.
Journal: Rheumatology (Oxford, England)
Published: March 18, 2025
Patterns of steroid use in patients with established rheumatoid arthritis commencing treatment with biologic or targeted synthetic DMARDs.
Journal: Rheumatology advances in practice
Published: March 17, 2025
Comparative Effectiveness of Abatacept Versus Adalimumab in Shared Epitope Positive and Negative Patients With Rheumatoid Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 09, 2024
Identifying Predictive Biomarkers of Response in Patients With Rheumatoid Arthritis Treated With Adalimumab Using Machine Learning Analysis of Whole-Blood Transcriptomics Data.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 30, 2024
An outbreak of Shiga toxin-producing Escherichia coli (STEC) O157:H7 associated with contaminated lettuce and the cascading risks from climate change, the United Kingdom, August to September 2022.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: September 06, 2024
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis.
Journal: Pharmaceutics
Published: April 17, 2024
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years.
Journal: Rheumatology and therapy
Published: August 23, 2023
Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis.
Journal: Expert review of clinical immunology
Published: March 28, 2023
HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: January 30, 2023
A proteomics study of rheumatoid arthritis patients on etanercept identifies putative biomarkers associated with clinical outcome measures.
Journal: Rheumatology (Oxford, England)
Published: January 08, 2023
Last Updated: 09/26/2026